Ampio begins Phase 1 clinical trial of inhaled Ampion for COVID-19
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it hasbegun recruiting and enrolling patients in a Phase Imulti-center, randomized, controlled trial for a total of 40... Read More
Thursday October 29, 2020 0 comments
RVC: Investments in “PandemicTech” companies on the rise
DENVER -- Rockies Venture Club made three investments in promising Colorado startups in September, two of which are "PandemicTech" companies representing a trend towards startups innovating in... Read More
Thursday October 22, 2020 0 comments
Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix
GOLDEN -- Reven today announced the U.S. Food and Drug Administration has approved its Investigational New Drug application in connection with its lead anti-inflammatory/anti-oxidant... Read More
Thursday October 22, 2020 0 comments
Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer
AURORA -- Summit Biolabs, Inc. , an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head neck cancer, and the Colorado Center for Personalized... Read More
Thursday October 15, 2020 0 comments
Radish's ChoiceView provides Voice-to-Visual Navigation on Mile High United Way 2-1-1 Help Center mobile calls
BOULDER -- Radish Systems announced deployment of its ChoiceView Visual Phonebot at Mile High United Way's 2-1-1 Help Center. ChoiceView allows callers with mobile devices to visually navigate... Read More
Friday October 2, 2020 0 comments
Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19
GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More
Wednesday September 30, 2020 0 comments
CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research
FORT COLLINS -- A team of scientists at Colorado State University was awarded a base contract worth $3.1 million from the National Institutes of Health to continue development... Read More
Tuesday September 22, 2020 0 comments
FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients
ENGLEWOOD-- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it has received an Investigational New Drug designation from the U.S. Food and Drug Administration, allowing the company to... Read More
Monday September 21, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
